查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464945

藥物注射系統市場：按產品類型、應用和最終用戶分類 - 全球預測 2024-2030

Drug Infusion Systems Market by Product Type (Infusion Pump, IV Disposable), Application (Diabetes, Gastrointestinal Diseases, Oncology), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥物注射系統市場規模為226.1億美元，2024年達240.1億美元，預計2030年將達到355.5億美元，複合年成長率為6.67%。

藥物注射系統是先進的醫療設備，旨在以受控方式將藥物輸送到患者體內。這些系統旨在確保以適當的速率、劑量和時間給藥，以達到預期的治療效果。藥物輸注系統依其功能分為多種類型，例如連續輸注幫浦、病人自控式鎮痛（PCA）幫浦、合成橡膠和注射式幫浦。使用藥物傳遞系統的主要優點是能夠傳遞一致且準確的劑量，這對於化療、胰島素治療和疼痛管理等精準強化治療至關重要。這些系統提供了藥物給藥的彈性，允許根據患者的特定需求和對治療的反應來調整給藥方案和劑量。藥物注射系統提高了患者的舒適度和便利性，減少了頻繁的手動給藥的需要，並且能夠長時間控制藥物輸送。癌症發生率的增加、對化療輸注幫浦的需求、技術創新和先進設備的持續採用正在推動藥物輸注系統市場的成長。然而，在網路威脅日益增加的情況下確保輸液系統的安全性和有效性是一項挑戰。物聯網和人工智慧在藥物傳輸技術中的個人化醫療的廣泛整合，以及對改善醫療基礎設施的不斷增加的投資，為市場滲透提供了廣闊的前景。

主要市場統計
基準年[2023] 226.1億美元
預測年份 [2024] 240.1億美元
預測年份 [2030] 355.5億美元
複合年成長率（%） 6.67%

產品類型 對慢性病的日益關注促使一次性拋棄式的使用增加

輸液幫浦是一種複雜的醫療設備，旨在將受管制量的液體（包括營養物質和藥物）輸送到患者體內。這些泵型態多種形式，包括門診泵、固定泵、注射泵和容積泵，每種泵都根據特定患者的需求量身定做。輸液幫浦在醫院環境和居家照護中都至關重要，它可以精確控制從化療到疼痛管理等各種治療的給藥速率和體積。輸液幫浦的可程式性和錯誤偵測警報可提高病患的安全性和治療效果。輸液拋棄式涵蓋了靜脈治療中一次性使用的一大類產品。此類別包括導管、管材、針頭、靜脈輸液袋等。靜脈拋棄式旨在最大限度地降低感染風險並確保無菌，對於將藥物、液體和營養物質直接注射到患者的血液中至關重要。它們在從急診室到長期護理設施的許多醫療機構中發揮著至關重要的作用，為挽救生命的治療提供了無菌途徑。方便、安全的一次性拋棄式已成為現代醫療保健的重要組成部分。

應用 頻繁使用藥物輸注系統以維持最佳血糖值並儘量減少糖尿病相關併發症

藥物輸注系統透過胰島素幫浦治療在糖尿病（尤其是第 1 型糖尿病）的治療中發揮著至關重要的作用。這些設備模仿健康胰臟的胰島素分泌，全天持續輸送短效或速效胰島素。此方法可根據血糖監測資料更準確地調整胰島素水平，降低高血糖和低血糖的風險，從而改善血糖控制和生活品質。在克隆氏症和潰瘍性大腸炎等慢性胃腸道疾病的治療中，藥物輸注系統用於將生物療法直接輸送到血液中。這種輸注療法對於對標準治療沒有反應的患者更有效。此外，透過控制藥物遞送，可以最小化與全身給藥相關的副作用。藥物注射系統在腫瘤學化療傳遞中非常重要，可以精確控制藥物傳遞的速度和時間，提高治療效果，同時最大限度地減少副作用。藥物輸注系統可用於連續輸注化療，這種化療可以長時間給藥，對某些類型的癌症更有效。此外，它還可以實現個人化的癌症治療方法，並可以適應患者特定的藥物治療方案和劑量。在小兒科領域，藥物注射系統透過提供適合兒童獨特需求的受控和精確的藥物傳遞而具有顯著的優勢。它可用於多種情況，從使用抗生素治療感染疾病到用於癌症治療的化療。藥物傳遞系統的準確性對於兒童族群至關重要，通常必須根據體重仔細計算劑量。

區域洞察

在美洲，特別是在美國和加拿大，由於糖尿病和癌症等慢性病的流行，對先進的給藥系統的需求量很大。美國市場的特點是醫療保健支出高，注重先進的醫療保健解決方案，青睞智慧、連網型和可攜式輸液設備。加拿大有一項支持先進醫療設備的醫療保健計劃。受經濟差異和醫療保健獲取的影響，亞太地區呈現多元化，消費者需求從基本輸液系統到高級輸液系統不等。由於政府推動醫療改革的舉措、醫療基礎設施的投資以及不斷成長的中產階級消費者基礎，中國市場正在蓬勃發展。日本在各個領域都展現出技術進步，尤其是醫療保健。由於人口老化以及對可在診所和家庭管理的高效醫療保健解決方案的需求，日本的藥物輸送系統方法強調創新和易用性。由於醫療保健成本的增加和意識的提高，印度的藥物注射系統市場正在成長。 MEA 地區是一個多元化的市場，擁有不同的醫療基礎設施和准入水準。波灣合作理事會(GCC) 國家正在醫療保健領域進行重大投資，包括在醫院和診所採用先進的藥物輸注系統。由於旨在改善醫療保健和與國際組織建立夥伴關係的舉措，非洲地區的市場潛力正在逐漸增加。在歐盟國家，由於有利的醫療政策、老年人口的增加和慢性病的增加，藥物輸注系統的引入正在擴大。歐盟對醫療設備有嚴格的法規，確保高品質和安全標準。最近的投資旨在開發智慧輸液系統，以提高患者的移動性和舒適度。

FPNV定位矩陣

FPNV定位矩陣對於評估藥物注射系統市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對藥物注射系統市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 注射系統市場的市場規模與預測是多少？

2.在藥物注射系統市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.注射系統市場的技術趨勢和法規結構是什麼？

4.注射系統市場主要廠商的市場佔有率為何？

5.進入注射系統市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症發生率增加以及化療輸注幫浦的需求
      • 增加輸液幫浦的引入
      • 對高效、準確的給藥系統的需求不斷成長以及向家庭醫療保健的轉變
    • 抑制因素
      • 採購和安裝的初始成本較高
    • 機會
      • 擴大物聯網和人工智慧在藥物傳輸技術中的個人化醫療的整合
      • 加大藥物注射系統的投資與研發力度
    • 任務
      • 在網路威脅日益嚴重的情況下確保輸液系統的安全性和有效性
  • 市場區隔分析
    • 產品類型：對慢性病的持續關注正在增加一次性靜脈拋棄式的使用。
    • 應用：大量使用藥物輸注系統以維持最佳血糖值並最大限度地減少糖尿病相關併發症
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章藥物注射系統市場：依產品類型

  • 點滴幫浦
  • 拋棄式靜脈注射

第7章藥物注射系統市場：依應用分類

  • 糖尿病
  • 消化系統疾病
  • 腫瘤學
  • 小兒科

第8章藥物注射系統市場：依最終使用者分類

  • 居家護理
  • 醫院
  • 專科診所

第9章美洲藥物注射系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥物注射系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲注射系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 費森尤斯·卡比 (Fresenius Kabi) 與梅奧診所 (Mayo Clinic) 簽署 Evenix 輸液系統協議
    • Insulet 為具有可調警報限值和Bolus洩漏警報功能的輸液幫浦系統申請了專利
    • Eitan Medical推出雲端基礎的輸液管理平台
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-F97DD5A7D582

[181 Pages Report] The Drug Infusion Systems Market size was estimated at USD 22.61 billion in 2023 and expected to reach USD 24.01 billion in 2024, at a CAGR 6.67% to reach USD 35.55 billion by 2030.

Drug infusion systems are sophisticated medical devices designed to deliver drugs into a patient's body in a controlled manner. These systems are engineered to ensure that medications are administered at the proper rate, volume, and duration to achieve the intended therapeutic effect. Drug infusion systems can be classified into various types based on their functionality, including continuous infusion pumps, patient-controlled analgesia (PCA) pumps, elastomeric pumps, and syringe pumps. The core advantage of using drug infusion systems lies in their ability to provide a consistent and precise dosage of medication, which is crucial for treatments that require a high level of accuracy, such as chemotherapy, insulin therapy, and pain management. These systems offer flexibility in drug administration, allowing for adjustments in dosing schedules and amounts based on the patient's specific needs and response to treatment. Drug infusion systems enhance patient comfort and convenience, reducing the need for frequent manual drug administration and enabling controlled drug delivery over extended periods. The growing incidence of cancer, the need for chemotherapy infusion pumps, and the increasing innovation and adoption of technologically advanced devices are driving the growth of the drug infusion systems market. However, ensuring the safety and efficacy of infusion systems amid rising cyber threats is challenging. The widening integration of IoT and AI for personalized medicine in drug delivery technologies and increasing investments in improving healthcare infrastructures offer vast prospects for market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 22.61 billion
Estimated Year [2024] USD 24.01 billion
Forecast Year [2030] USD 35.55 billion
CAGR (%) 6.67%

Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases

The infusion pumps are sophisticated medical devices designed for delivering fluids, including nutrients and medications, into a patient's body in controlled amounts. These pumps come in various forms, including ambulatory, stationary, syringe, and volumetric pumps, each tailored to specific patient needs. Infusion pumps are essential in both hospital settings and home care and offer precise control over the delivery rates and volume, accommodating a wide range of therapies, from chemotherapy to pain management. The programmability and alarms of infusion pumps for error detection enhance patient safety and treatment efficacy. IV disposables encompass a broad category of products intended for single use in intravenous therapy. This category includes catheters, tubing, needles, and IV bags. IV disposables are designed to minimize the risk of infection and ensure sterility and are crucial in administering drugs, fluids, and nutrients directly into a patient's bloodstream. They are pivotal in many medical settings, ranging from emergency rooms to long-term care facilities, providing a sterile pathway for administering life-saving treatments. The convenience and safety aspects of IV disposables make them indispensable in modern healthcare.

Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications

Drug infusion systems play a pivotal role in the management of diabetes, particularly Type 1 diabetes, through insulin pump therapy. These devices continuously deliver short-acting or rapid-acting insulin throughout the day, mimicking how a healthy pancreas releases insulin. This method can improve glycemic control and quality of life by allowing more precise adjustment of insulin levels in response to glucose monitoring data, reducing both hyperglycemia and the risk of hypoglycemia. In managing chronic gastrointestinal diseases such as Crohn's disease or ulcerative colitis, drug infusion systems are utilized to administer biological therapies directly into the bloodstream. These infusion therapies are more effective for the ones who do not respond to standard treatment. Additionally, the controlled delivery of drugs can minimize side effects associated with systemic administration. Drug infusion systems are critically important in oncology for chemotherapy delivery and enable precise control over the rate and timing of drug delivery, which can enhance the efficacy of the treatment while minimizing its side effects. Drug infusion systems can be used for continuous infusion chemotherapy, where drugs are administered over a long period, which may be more effective for certain types of cancer. Furthermore, they allow for a more personalized approach to cancer treatment, accommodating patient-specific drug regimens and dosages. In pediatrics, drug infusion systems offer significant advantages by providing controlled and accurate drug delivery suitable for children's unique requirements. They are used in various scenarios, from antibiotic administration for infections to chemotherapy for cancer treatment. The precision of drug infusion systems is crucial for the pediatric population, where dosages often must be carefully calculated based on weight.

Regional Insights

In the Americas, particularly the United States and Canada, there is a high demand for advanced drug infusion systems due to the prevalence of chronic diseases, including diabetes and cancer. The U.S. market is characterized by high healthcare spending and a strong emphasis on advanced healthcare solutions, leading to a preference for smart, connected, and portable infusion devices. Canada has healthcare initiatives supporting advanced medical devices. The Asia Pacific region is diverse, with consumer needs ranging from basic to advanced infusion systems, influenced by economic disparities and healthcare access. China's market is booming due to government initiatives promoting healthcare reform, investment in healthcare infrastructure, and a growing middle-class consumer base. Japan showcases technological advancements across various sectors, with healthcare being a prime focus. Japan's approach to drug infusion systems emphasizes innovation and user-friendliness and is driven by an aging population and the necessity for efficient healthcare solutions that can be managed both in clinical settings and at home. India's drug infusion systems market is growing with increasing healthcare spending and awareness. The MEA region presents a diverse market with varying healthcare infrastructure and access levels. The Gulf Cooperation Council (GCC) countries are witnessing significant investments in healthcare, including the adoption of advanced drug infusion systems in hospitals and clinics. In the African region, initiatives aimed at healthcare improvement and partnerships with international organizations are gradually enhancing the market potential in these regions.EU countries exhibit a growing adoption of drug infusion systems, driven by favorable healthcare policies, an increase in the geriatric population, and a rise in chronic conditions. The EU has stringent regulations regarding medical devices, ensuring high quality and safety standards. Recent investments have been channeled toward developing smart infusion systems that promote patient mobility and comfort.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Infusion Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Infusion Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Infusion Systems Market, highlighting leading vendors and their innovative profiles. These include AKAS Infusions, B. Braun SE, Baxter International, Inc., Becton, Dickinson, and Company, Debiotech S.A., Eitan Medical, Flowonix Medical Inc., Fresenius Kabi AG, Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., Insulet Corporation, Intera Oncology Inc., IRADIMED CORPORATION, Ivenix Inc., Medtronic Plc, Micrel Medical Devices SA, Microport Scientific Corporation, MOOG, Inc., Promecon GmbH, SINO MDT, Smiths Group plc, Tandem Diabetes Care, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Infusion Pump
    • IV Disposable
  • Application
    • Diabetes
    • Gastrointestinal Diseases
    • Oncology
    • Pediatrics
  • End-user
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug Infusion Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Infusion Systems Market?

3. What are the technology trends and regulatory frameworks in the Drug Infusion Systems Market?

4. What is the market share of the leading vendors in the Drug Infusion Systems Market?

5. Which modes and strategic moves are suitable for entering the Drug Infusion Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of cancer and the need for chemotherapy infusion pumps
      • 5.1.1.2. Increasing adoption of infusion pumps
      • 5.1.1.3. Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. High initial cost of procurement and installation
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing integration of IoT and AI for personalized medicine in drug delivery technologies
      • 5.1.3.2. Increasing investments and R&D in drug infusion system
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring safety and efficacy of infusion systems amid rising cyber threats
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases
    • 5.2.2. Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Drug Infusion Systems Market, by Product Type

  • 6.1. Introduction
  • 6.2. Infusion Pump
  • 6.3. IV Disposable

7. Drug Infusion Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Diabetes
  • 7.3. Gastrointestinal Diseases
  • 7.4. Oncology
  • 7.5. Pediatrics

8. Drug Infusion Systems Market, by End-user

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Drug Infusion Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Infusion Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Infusion Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Fresenius Kabi, Mayo Clinic Ink Deal On Ivenix Infusion System
    • 12.3.2. Insulet Files Patent On Infusion Pump System With Adjustable Alarm Limits And Missed Bolus Alarm
    • 12.3.3. Eitan Medical Launched Cloud-Based Infusion Management Platform
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG INFUSION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG INFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG INFUSION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG INFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023